| Literature DB >> 18394173 |
Shyam Sundar Ganguly1, Mohammed Ali Al-Shafaee, Kamlesh Bhargava, Kalyan Kanti Duttagupta.
Abstract
BACKGROUND: The importance of prediabetes and prehypertension has been demonstrated in several studies especially for primary prevention of CVD. A recent community based cross-sectional study revealed that 40.9 percent Omani adults are prediabetics. This study was undertaken to estimate the prevalence of prehypertension and associated cardiovascular risk profiles in prediabetics. To best of our knowledge, this is the first report on this subject.Entities:
Mesh:
Year: 2008 PMID: 18394173 PMCID: PMC2386813 DOI: 10.1186/1471-2458-8-108
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Characteristics and lipid profiles of the prediabetic study group
| Characteristics | Total (n = 327) | Male (n = 142) | Female (n = 185) | p |
| Mean ± SD | Mean ± SD | Mean ± SD | ||
| Age (years) | 35.0 ± 12.0 | 33.4 ± 12.3 | 36.2 ± 12.0 | 0.039 |
| FPG (mmol/L) | 5.9 ± 0.4 | 5.9 ± 0.4 | 5.8 ± 0.4 | 0.059 |
| OGT (mmol/L) | 7.1 ± 1.8 | 6.6 ± 1.7 | 7.6 ± 1.7 | <0.001 |
| SBP (mmol/L) | 125.7 ± 15.9 | 128.6 ± 16.4 | 123.4 ± 15.2 | 0.003 |
| DBP (mmol/L) | 78.9 ± 9.9 | 80.3 ± 10.0 | 77.8 ± 9.8 | 0.027 |
| BMI (kg/m2) | 27.1 ± 5.6 | 26.2 ± 4.7 | 27.9 ± 6.2 | 0.004 |
| WHR | 0.89 ± 0.08 | 0.90 ± 0.07 | 0.88 ± 0.09 | 0.014 |
| TC (mmol/L) | 5.0 ± 1.1 | 5.0 ± 1.0 | 5.1 ± 1.1 | 0.492 |
| LDL-C (mmol/L) | 3.4 ± 0.9 | 3.4 ± 0.9 | 3.4 ± 0.9 | 0.595 |
| HDL-C (mmol/L) | 1.2 ± 0.3 | 1.1 ± 0.3 | 1.3 ± 0.3 | <0.001 |
| TG (mmol/L) | 0.9 ± 0.6 | 1.0 ± 0.7 | 0.8 ± 0.5 | <0.001 |
| Smoking history (%) | 14.1% | 18.3% | 10.8% | 0.040 |
| BP status (%) | ||||
| Normotensive | 21.7% | 16.2% | 25.9% | 0.024 |
| Prehypertensive | 54.1% | 53.5% | 54.6% | |
| Hypertensive | 24.2% | 30.3% | 19.5% | |
Demographic, Metabolic and Behavioral characteristics of prediabetic subjects by BP groups (Mean ± SD)
| Variable | Normotensive (n = 71) | Prehypertensive (n = 177) | p* | Hypertensive (n = 79) | p↑ |
| Age (years) | 33.1 ± 9.8 | 33.2 ± 11.0 | 0.979 | 40.7 ± 14.7 | <0.001 |
| Sex, male/female | 23/48 | 76/101 | 0.064 | 43/36 | 0.044 |
| FPG, (mmol/L) | 5.8 ± 0.4 | 5.9 ± 0.4 | 0.263 | 6.0 ± 0.4 | 0.050 |
| IGT (mmol/L) | 6.7 ± 1.7 | 7.2 ± 1.8 | 0.062 | 7.4 ± 1.8 | 0.567 |
| TC (mmol/L) | 4.8 ± 0.9 | 5.0 ± 1.0 | 0.238 | 5.3 ± 1.2 | 0.076 |
| LDL-C (mmol/L) | 3.3 ± 0.8 | 3.4 ± 0.9 | 0.412 | 3.6 ± 1.0 | 0.050 |
| HDL-C (mmol/L) | 1.2 ± 0.3 | 1.2 ± 0.3 | 0.756 | 1.2 ± 0.4 | 0.972 |
| TG (mmol/L) | 0.7 ± 0.5 | 0.9 ± 0.6 | 0.011 | 0.9 ± 0.6 | 0.771 |
| BMI (kg/m2) | 25.2 ± 4.6 | 27.6 ± 5.8 | 0.002 | 27.7 ± 5.8 | 0.899 |
| WHR | 0.87 ± 0.09 | 0.89 ± 0.07 | 0.740 | 0.92 ± 0.08 | 0.010 |
| Smoking history % | 19.7% | 13.0% | 0.179 | 11.4% | 0.720 |
* p-values for comparison between normotensive and prehypertensive subjects
↑ p-values for comparison between prehypertensive and hypertensive subjects
Mean age, metabolic parameters and BMI by BP groups and sex
| Variable | Normotensive (n = 71) | Prehypertensive (n = 177) | Hypertensive (n = 79) | ||||||
| Males (n = 23) | Females (n = 48) | Males (n = 76) | Females (n = 101) | Males (n = 43) | Females (n = 36) | ||||
| Mean ± SD | Mean ± SD | P | Mean ± SD | Mean ± SD | p | Mean ± SD | Mean ± SD | p | |
| Age (years) | 32.3 ± 10.3 | 33.5 ± 9.7 | 0.634 | 30.9 ± 10.2 | 34.9 ± 11.3 | 0.018 | 38.3 ± 15.1 | 43.5 ± 14.0 | 0.123 |
| FPG (mmol/L) | 5.8 ± 0.3 | 5.8 ± 0.4 | 0.402 | 5.9 ± 0.4 | 5.8 ± 0.4 | 0.321 | 6.0 ± 0.4 | 6.0 ± 0.4 | 0.464 |
| IGT (mmol/L) | 5.9 ± 1.5 | 7.1 ± 1.7 | 0.005 | 6.6 ± 1.7 | 7.7 ± 1.7 | <0.001 | 6.9 ± 1.9 | 7.9 ± 1.6 | 0.011 |
| TC (mmol/L) | 4.6 ± 0.9 | 4.9 ± 0.9 | 0.248 | 5.0 ± 0.9 | 5.0 ± 1.1 | 0.951 | 5.1 ± 1.2 | 5.4 ± 1.2 | 0.213 |
| LDL-C (mmol/L) | 3.1 ± 0.8 | 3.3 ± 0.8 | 0.400 | 3.4 ± 0.8 | 3.4 ± 1.0 | 0.835 | 3.5 ± 1.1 | 3.8 ± 1.0 | 0.183 |
| HDL-C (mmol/L) | 1.1 ± 0.2 | 1.3 ± 0.3 | 0.005 | 1.1 ± 0.3 | 1.3 ± 0.3 | <0.001 | 1.2 ± 0.4 | 1.2 ± 0.3 | 0.878 |
| TG (mmol/L) | 0.8 ± 0.4 | 0.6 ± 0.5 | 0.101 | 1.1 ± 0.8 | 0.7 ± 0.5 | <0.001 | 0.9 ± 0.6 | 1.0 ± 0.6 | 0.633 |
| BMI, (kg/m2) | 25.5 ± 3.9 | 25.0 ± 4.9 | 0.703 | 26.2 ± 4.9 | 28.7 ± 6.2 | 0.004 | 26.4 ± 4.8 | 29.4 ± 6.6 | 0.022 |
| WHR | 0.91 ± 0.07 | 0.86 ± 0.10 | 0.049 | 0.90 ± 0.08 | 0.88 ± 0.08 | 0.133 | 0.92 ± 0.07 | 0.92 ± 0.09 | 0.835 |
Prevalence of risk factors (%) for CVD by BP groups and gender in the prediabetic subjects
| Variable | Males (n = 142) | Females (n = 185) | |||||||||
| Normal (n = 23) | Pre-HTN (n = 76) | OR (95%CI) | HTN (n = 43) | OR (95%CI) | Normal (n = 48) | Pre-HTN (n = 100) | OR (95%CI) | HTN (n = 36) | OR (95%CI) | ||
| TC (≥5.0 mmol/L) | 39.1 | 51.3 | 1.6 (0.6, 4.7) | 48.8 | 1.5 (0.5,4.7) | 43.8 | 47.0 | 1.2 (0.6, 2.4) | 63.9 | 2.3 (0.9, 6.1) | |
| TG (≥ 1.7 mmol/L) | - | 23.7 | - | 11.6 | - | 4.2 | 5.1 | 1.2 (0.2,9.5) | 11.1 | 2.9 (0.4,24.3) | |
| LDL-C (≥ 3.0 mmol/L) | 59.1 | 71.1 | 1.7 (0.6,5.1) | 73.7 | 1.9 (0.6,6.9) | 66.7 | 71.3 | 1.3 (0.6,2.8) | 75.0 | 1.5 (0.5,4.4) | |
| HDL-C (≤ 1.03 mmol/L) | 34.8 | 52.6 | 2.1 (0.7, 6.2) | 32.6 | 0.9 (0.3,3.0) | 18.8 | 18.0 | 1.0 (0.4,2.5) | 25.0 | 1.5 (0.5,4.6) | |
| BMI (≥25.0 kg/m2) | 60.9 | 59.2 | 0.9 (0.3,2.7) | 53.5 | 0.7 (0.2,2.3) | 39.6 | 72.3 | 4.0 (1.8,8.8) | 72.2 | 4.0 (1.4,11.3) | |
| Abnormal WHR (%) | 17.4 | 31.7 | 2.2 (0.6, 8.5) | 34.9 | 2.5 (0.6, 10.7) | 56.3 | 65.3 | 1.5 (0.7, 3.1) | 77.8 | 2.7 (0.9, 8.1) | |
| Smoking history (%) | 26.1 | 18.4 | 0.6 (0.2,2.2) | 14.0 | 0.5 (0.1,1.9) | 16.7 | 8.9 | 0.5 (0.2,1.5) | 8.3 | 0.5 (0.1,2.1) | |
Determinants of prehypertension versus normotension based on fitting multiple logistic regression models in the prediabetic subjects
| Variable | Adjusted ORs after including all the factors in the model | Adjusted ORs after eliminating the insignificant factors using stepwise regression | |||||
| OR | 95% CI | P | OR | 95% CI | P | ||
| Male sex | 2.41 | 1.11, 5.21 | 0.026 | 2.30 | 1.21, 4.38 | 0.011 | |
| Blood glucose (IGT mmol/l) | 1.28 | 1.06, 1.53 | 0.009 | 1.26 | 1.06, 1.50 | 0.009 | |
| BMI (≥25 kg/m2) | 1.87 | 1.00, 3.50 | 0.050 | 2.25 | 1.26, 4.02 | 0.006 | |
The OR for blood glucose was continuous and calculated for 1 unit.